Dechra Pharmaceuticals PLC
DCHPF · OTC
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $6,300 | $95,500 | $76,670 | $52,200 |
| Dep. & Amort. | $89,700 | $89,100 | -$125,298 | $14,200 |
| Deferred Tax | $10,600 | -$39,600 | $0 | -$28,400 |
| Stock-Based Comp. | -$800 | $3,300 | $0 | $1,500 |
| Change in WC | -$60,200 | -$27,800 | -$49,732 | -$8,700 |
| Other Non-Cash | $18,000 | $2,400 | -$67,829 | $75,600 |
| Operating Cash Flow | $63,600 | $122,900 | $123,087 | $106,400 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$30,300 | -$77,600 | -$186,219 | -$49,200 |
| Net Acquisitions | -$396,900 | -$800 | -$967 | -$32,800 |
| Inv. Purchases | $0 | $0 | -$1,105 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $1,000 | $100 | $276 | $500 |
| Investing Cash Flow | -$426,200 | -$78,300 | -$188,015 | -$81,500 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $181,900 | $2,300 | $3,177 | $131,500 |
| Stock Repurch. | -$15,100 | $3,600 | $0 | $140,200 |
| Dividends Paid | -$51,700 | -$44,800 | -$52,357 | -$33,300 |
| Other Fin. Act. | $368,200 | -$1,300 | $0 | $152,200 |
| Financing Cash Flow | $316,500 | -$46,100 | -$76,118 | $118,900 |
| Forex Effect | -$400 | $4,000 | $0 | $3,300 |
| Net Chg. in Cash | -$46,500 | $2,500 | $0 | $147,100 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $120,900 | $118,400 | $0 | $80,300 |
| End Cash | $74,400 | $120,900 | $0 | $227,400 |
| Free Cash Flow | $33,300 | $45,300 | $96,978 | $57,200 |